PHARMACLIN LIMITED

Company Registration Number:
08919153 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

PHARMACLIN LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

PHARMACLIN LIMITED

Company Information

for the Period Ended 31 March 2025




Registered office: 22
Lindisfarne Priory
Bedford
MK41 0RE
Company Registration Number: 08919153 (England and Wales)

PHARMACLIN LIMITED

Balance sheet

As at 31 March 2025


2025
£

2024
£
Fixed Assets: 1,200 1,200
Current assets: 86,058 182,285
Creditors: amounts falling due within one year: ( 44,128 ) ( 70,313 )
Net current assets (liabilities): 41,930 111,972
Total assets less current liabilities: 43,130 113,172
Total net assets (liabilities): 43,130 113,172
Capital and reserves: 43,130 113,172

PHARMACLIN LIMITED

Balance sheet continued

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 30 December 2025
And Signed On Behalf Of The Board By:

Name: Subbaraju Gadiraju
Status: Director

The notes form part of these financial statements

PHARMACLIN LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Employee Information

    Average number of employees: 2

PHARMACLIN LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Off balance sheet disclosure

    No